Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

45 results
Display

Expression of c-Met in ovarian epithelial tumor

Kim BS, Park IS, Lee YS, Koo TB, Park TI

  • KMID: 2244531
  • Korean J Gynecol Oncol.
  • 2007 Dec;18(4):284-288.
OBJECTIVE: This study was performed to evaluate the expression of c-Met in epithelial ovarian carcinoma. METHODS: Paraffin-embedded tissues from 50 epithelial ovarian adenocarcinomas were stained immunohistochemically for c-Met expression. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of the c-Met Proteins in Malignant Skin Cancers

Lee YJ, Kim DH, Lee SH, Kim DW, Nam HS, Cho MK

BACKGROUND: The expression of c-Met is substantially elevated in most malignant human cancers. We therefore searched for c-Met expression and compared the expression level among malignant skin cancers. OBJECTIVE: The aim...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-MET in Invasive Meningioma

Yun S, Koh JM, Lee KS, Seo AN, Nam KH, Choe G

BACKGROUND: Meningiomas show high recurrence rates even after curative tumor removal. The invasiveness of meningiomas may contribute to their high recurrence rates. Recently, c-MET and hepatocyte growth factor (HGF) have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-Met Is Different along the Location and Associated with Lymph Node Metastasis of Head and Neck Carcinoma

Choe JY, Yun JY, Nam SJ, Kim JE

  • KMID: 2012050
  • Korean J Pathol.
  • 2012 Dec;46(6):515-522.
BACKGROUND: Activation of the c-Met pathway is involved in cancer progression and the prognosis. We aimed to identify any association of c-Met protein expression with a number of clinicopathologic variables...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-Met in hepatocellular carcinoma

Roh HR, Lee HJ, Kim SB, Kim SH, Suh KS, Lee KU

  • KMID: 2244336
  • Korean J Hepatobiliary Pancreat Surg.
  • 2001 Dec;5(2):35-42.
BACKGROUND/AIMS: The c-met proto-oncogene encodes the tyrosine kinase receptor for hepatocyte growth factor (HGF), a potent mitogen and motogen for epithelial cells. Because of its profound effects on cell growth...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlation of long interspersed element-1 open reading frame 1 and c-Met proto-oncogene protein expression in primary and recurrent colorectal cancers

Jeon KY, Ko EJ, Chang HK, Lee SH, Ahn BK, Ock MS, Cha HJ

Background: Colorectal cancer is one of the most common cancers worldwide. Colorectal cancer that has recurred and metastasized to other organs also has a very poor prognosis. According to recent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An alternatively spliced form of Met receptor is tumorigenic

Lee JH, Gao CF, Lee CC, Kim MD, Vande Woude GF

  • KMID: 1098091
  • Exp Mol Med.
  • 2006 Oct;38(5):565-573.
The Met tyrosine kinase receptor is a widely expressed molecule, which mediates pleiotropic cellular responses following activation by its ligand, hepatocyte growth factor/scatter factor (HGF/SF). Previously, one of the authors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of the c-Met, p53 and Ki-67 Proteins in Astrocytic Tumors

Cho BH, Cho BM, Ahn HK, Lim WJ, Park SH, Oh SM

  • KMID: 1955777
  • J Korean Neurosurg Soc.
  • 2003 Sep;34(3):202-206.
OBJECTIVE: The pathologic diagnosis of the astrocytoma has been primarily based on the histologic grading, however, there are some discrepancies among the pathologists on the tumor grading. Met protein, known...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Impact of Capmatinib in the Treatment of Advanced Non–Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification

Choi W, Park SY, Lee Y, Lim KY, Park M, Lee GK, Han JY

Purpose Capmatinib, an oral MET kinase inhibitor, has demonstrated its efficacy against non–small cell lung cancer (NSCLC) with MET dysregulation. We investigated its clinical impact in advanced NSCLC with MET...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of HGF/c-Met in Serum-Starved ARPE-19 Cells

Jun EJ, Kim HS, Kim YH

PURPOSE: Hepatocyte growth factor (HGF) and its receptor (HGFR/c-Met) regulate motility, mitogenesis, and morphogenesis in a cell type-dependent fashion. We report the role of HGF and c-Met on stress-induced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of Hepatocyte Growth Factor/c-met by RT-PCR in Meningiomas

Kim NR, Chae YS, Lim WJ, Cho SJ

BACKGROUND: Hepatocyte growth factor (HGF) is a potent mitogenic cytokine. C-met protein, which is known to be the HGF receptor has transmembrane tyrosine kinase activity and is encoded by the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-met Gene in Thyroid Tumors

Cha HJ, Cho SJ, Yoo CW, Chang WY, Kang HJ, Joo SH, Park CH, Park CJ

  • KMID: 1896216
  • J Korean Surg Soc.
  • 2004 Oct;67(4):279-285.
PURPOSE: The hepatocyte growth factor, (HGF)/c-Met, pathway may play various roles in the carcinogenesis of various organs. HGF, a ligand for c-Met, is a pleiotrophic factor that was originally identified...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
c-Met Expression in Colorectal Carcinoma and Adenomas: Correlation with Clinicopathologic Parameters

Kim J, Kim JY, Lee WJ, Cho SJ, Min BW, Um JW, Cho MY, Suh SO, Moon HY, Hwang CW

  • KMID: 1566536
  • J Korean Soc Coloproctol.
  • 2004 Aug;20(4):205-210.
PURPOSE: Hepatocyte growth factor (HGF) stimulates proliferation, migration, and morphogenesis of epithelial cells by specifically binding to its receptor c-met. Abnomalities of the c-met oncogene have been studied in cancers...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis

Pyo JS, Kang G, Cho H

PURPOSE: The aim of the present study was to elucidate the clinicopathological significance and diagnostic accuracy of immunohistochemistry (IHC) for determining the mesenchymal epidermal transition (c-MET) expression in patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Recepteur D'origine Nantais on Gastric Cancer Development and Progression

Yang SY, Nguyen TT, Ung TT, Jung YD

Recepteur d'origine nantais (RON) is a receptor tyrosine kinase belonging to the subfamily of which c-MET is the prototype. Large epidemiologic studies have confirmed the strong association between RON and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of c-erbB-2 and c-met Proteins in Gastric Adenoma and Adenocarcinoma

Lee SW, Kang SB, Kim YS, Nam SW, Lee DS, Lee HK, Han SW

  • KMID: 782837
  • Korean J Gastroenterol.
  • 2007 Mar;49(3):152-157.
BACKGROUND/AIMS: The aim of this study was to investigate the immunohistochemical overexpression of c-erbB-2 and c-met proteins according to the histopathological parameters such as grade of dysplasia, histological type, depth...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression of the c-met Gene in Invasive Ductal Carcinomas

Oh HE, Choi WH, Kim HS, Jung SY, Yoon CH, Park CH, Cho SJ, Nam ES, Ahn HK, Shin HS

PURPOSE: The c-met protein, known as the hepatocyte growth factor (HGF) receptor, is a transmembrane 190 kDa heterodimer having tyrosine kinase activity, and it is encoded by the c-met oncogene....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expressions and Clinical Significances of c-met, c-erbB-2, COX-2, and IL-6 in the Biliary Tract Cancers

Joo HH, Song EY, Jin SH, Oh SH, Choi YK

  • KMID: 937932
  • Korean J Gastroenterol.
  • 2007 Dec;50(6):370-378.
BACKGROUND/AIMS: c-met, c-erbB-2, interleukin (IL)-6, and cyclooxygenase (COX)-2 expressions are considered to be implicated in the carcinogenesis and progression of cholangiocarcinoma, but the molecular pathogenesis of cholangiocarcinoma is still...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
MET Expression in Sporadic Renal Cell Carcinomas

Choi JS, Kim MK, Seo JW, Choi YL, Kim DH, Chun YK, Ko YH

Although germline mutations of met proto-oncogene on human chromosome 7q31-34 have been known as useful molecular markers of hereditary papillary renal cell carcinoma (RCC), the expression of MET, a product...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with In Vitro Anti-Tumor Effects

Ndolo KM, An SJ, Park KR, Lee HJ, Yoon KB, Kim YC, Han SY

The c-Met protein is a receptor tyrosine kinase involved in cell growth, proliferation, survival, and angiogenesis of several human tumors. Overexpression of c-Met has been found in gastric cancers and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr